Device Trial Radar · NCT02292212
Clinical Study of Asahi ViE Dialyzer in Canada
Last checked: Nov 21, 2026Latest source record: Dec 11, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
17
Actual
Start
Nov 24, 2014
Primary completion
Nov 6, 2015
Study completion Nov 6, 2015
Sponsor
- Lead sponsor
- Asahi Kasei Medical Co., Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 17, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to obtain performance data on the Asahi ViE-21 dialyzer (ViE-21) .
Conditions
- Kidney Failure, Chronic
Interventions
ViE-21Device
The subjects will be undergone three times KUF measurement sessions and three times blood sampling sessions during study period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Removal Rate of UreaTime frame: Week 1 (Pre-ViE phase), 7, 13 (ViE phase)
7 more outcomes with a free account
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.